IBXO Options Underwriting Agreement — US Based Investor

Imagion Biosystems is pleased to announce it has entered into an options underwriting agreement (Underwriting Agreement) with Mercer Street Global…


Appendix 3Y Change of Director's Interest Notice

The document "Appendix 3Y Change of Director's Interest Notice" was lodged with ASX on 22 November, 2021. Please click to review the full announcement at ASX.


Application for quotation of +securities

The document "Application for quotation of +securities" was lodged with ASX on November 18, 2021. Please click to review the full announcement at ASX.


Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001

The following cleansing notice was lodged with ASX on 18 November 2021: Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 12…


Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001

Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 29 October 2021 and 4 November 2021 the Company issued 7,075,649 fully paid…


Appendix 3Y Change of Director's Interest Notice

The document "Appendix 3Y Change of Director's Interest Notice" was lodged with ASX on 11 November 2021. Please click the review the full announcement at ASX.


Application for quotation of +securities

The document "Application for quotation of +securities" was lodged with ASX on November 11, 2021. Please click to review the full announcement at ASX.


Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001

Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 5 November 2021 and 11 November 2021 the Company issued 14,490,291 fully…


Response to ASX Price Query

The document "Response to ASX Price Query" was lodged with ASX on 9 November, 2021. Please click to review the full announcement at ASX.


Application for quotation of +securities

The document "Application for quotation of +securities" was lodged with ASX on 4 November 2021. Please click to review the full announcement at ASX.